Postmarketing surveillance: Accuracy of patient drug attribution judgments
- 1 July 1990
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 48 (1) , 102-107
- https://doi.org/10.1038/clpt.1990.123
Abstract
Data from two samples of ambulatory patients participating in a postmarketing surveillance study, one receiving antibiotics and another receiving tricyclic antidepressant agents, are presented, indicating that patients appear to be capable of correctly discriminating probable adverse drug reactions from other adverse clinical events. However, attribution accuracy depended both on the surviellance method on how reports of the adverse clinical events were obtained. Discrimination was better when patients were reporting adverse clinical events spontaneously wthan when the interviewer probed for recall in a systematic inquiry. Discrimination was also better when the adverse clinical events were obtained from a staff-initiated surveillance method than from a self-monitoring, patient-initiated telephone-reporting method-probably because the latter method generates an excessively strong tendency to report mainly those adverse clinical event suspected of being drug related.This publication has 0 references indexed in Scilit: